There is no effect of not having the test done before the bivalent shot and you can just get the vaccine as normal. The bivalent HPV vaccine protects against HPV subtypes 16 and 18 and is indicated for women aged 9-45 years. According to the guidelines, the HPV vaccine has significant protective efficacy for women who have been reinfected with previous vaccine types of HPV. Statistics show that the HPV vaccine is recommended for women of the appropriate age regardless of the presence or absence of HPV infection or cervical cytologic abnormalities, and that there is no need to routinely perform cytologic and HPV testing prior to vaccination. After vaccination, the patient should be kept under observation for at least 30 minutes to prevent allergies and other adverse reactions. After vaccination, regular cervical cancer screening should still be performed to prevent the disease. If women experience adverse reactions such as headache or allergy after vaccination, it is recommended that they consult a doctor in a timely manner and under the doctor’s guidance, complete the relevant examinations to identify the cause of the disease and treat it appropriately.